查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1887115

医疗营养市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察，以及2024-2032年预测

Medical Nutrition Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 195 Pages | 商品交期: 请询问到货日

价格

医疗营养市场成长因素

随着慢性病发病率的上升、临床营养意识的增强以及全球医疗保健系统日益认识到营养疗法在急长期照护中的重要性，全球医疗营养市场持续稳步增长。根据本报告，在全球人口老化和医疗营养疗法（MNT）需求不断增长的推动下，2024年市场规模达到512.6亿美元。预计2025年，市场规模将进一步成长至529.4亿美元，2032年将达到850.5亿美元，预测期内复合年增长率（CAGR）为7.0%。 2024年，北美地区引领全球市场，占总营收的34.96%。这得益于该地区完善的医疗保健基础设施、慢性病高发生率以及为推进临床营养解决方案而不断扩大的合作关係。

市场关键洞察

医学营养疗法 (MNT) 是一种个人化的营养干预措施，用于管理糖尿病、胃肠道疾病、心血管疾病、慢性呼吸系统疾病和肾臟疾病等。这种方法利用临床营养师提供的营养教育和行为咨询，作为多学科医疗照护的一部分。近年来，由于全球对营养在预防和管理慢性病方面重要性的认识不断提高，市场需求激增。

市场处于半一体化状态，主要参与者包括雅培、雀巢、纽迪希亚（达能）、贝朗、费森尤斯卡比和利洁时集团。这些公司不断扩展其产品组合併获得监管部门的批准，以推出针对特定疾病和以患者为中心的营养产品。例如，2023年4月，纽迪希亚（Nutricia）在美国推出了一款支持突触强化的记忆力补充剂。

市场动态

驱动因素：慢性疾病负担加重

慢性疾病盛行率的不断上升显着推动了市场需求。癌症、帕金森氏症和神经系统疾病等疾病常常会影响正常的营养摄取。根据美国国家帕金森氏症协会统计，到2030年，北美将有130万人罹患帕金森氏症。同样，老化也是需要临床营养治疗的慢性疾病的主要驱动因素。在美国，预计2022年65岁以上人口将占总人口的17.3%，到2040年将达到22.0%。

人们对家庭医疗营养日益增长的兴趣也在推动市场需求。由于便利性、更高的行动能力和更好的生活质量，老年患者越来越倾向于在家中接受临床营养服务。

阻碍因素：有限的报销政策

特殊医学用途食品和营养疗法的保险覆盖范围因地区而异。虽然法国、德国、西班牙和荷兰等欧洲国家提供充足的报销，但在美国，医院外的报销范围有限。这限制了低收入患者获得服务的机会。此外，缺乏临床营养技术研究的经济诱因可能会阻碍创新。

机会：人工智慧驱动的个人化营养

对疾病特异性和个人化营养产品的需求不断增长，为製造商带来了巨大的机会。像雅培这样的公司正在加大对人工智慧驱动的营养解决方案的研发投入（到2023年将达到27.41亿美元），用于治疗胃肠道疾病、免疫健康和代谢性疾病。人工智慧的进步使得为重症患者提供精准营养输送和即时监测成为可能。

市场趋势

一个关键的市场趋势是转向疾病特异性配方，包括针对癌症、肾臟病和代谢紊乱的配方。各公司正在推出专门的配方以改善治疗效果。例如，雅培推出了 Similac PM 60/40 代谢配方，以帮助患有某些肾臟疾病的婴儿。

个人化营养也正在蓬勃发展，尤其是在日本，53% 的消费者表示对个人化营养解决方案感兴趣。此外，全球对预防医学的关注度也不断提高，这使得临床营养成为疾病预防的重要工具。

区域展望

北美

北美引领全球市场，预计到 2024 年市场规模将达到 179.2 亿美元，主要得益于强大的研发、产品发表和合作关係。各公司经常在美国主要的医学会议上展示新的解决方案。百特公司于 2022 年推出的 ExactaMix Pro 就是该地区创新不断增长的一个例子。

欧洲

在有利的医保报销政策和强有力的研究合作（例如费森尤斯卡比与欧洲重症监护医学中心 (ESICM) 的合作）的推动下，欧洲将在 2024 年占第二大市场占有率。该合作支持临床营养教育和重症监护营养。

亚太地区

预计亚太地区在 2025 年至 2032 年间将保持温和增长，这主要得益于人口老化加剧以及人们对特定疾病营养的认识不断提高。中国、印度和日本的经济发展和医疗保健支出的成长正在推动市场扩张。

拉丁美洲与中东/非洲

由于医疗保健服务的改善、慢性病盛行率的上升以及人们对营养疗法的认识不断提高，这些地区将实现稳步增长。

2025年至2032年的复合年增长率将为7.0%。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 各国及各次区域主要慢性病盛行率（2023/2024）
  • 主要公司新产品发布
  • 主要产业趋势（併购、合作及其他）

第五章：全球医疗营养市场分析、洞察与预测（2019-2032）

  • 市场分析、洞察与预测 - 依类型划分
    • 服务
      • 营养评估
      • 膳食准备与配送
      • 餵食辅助
      • 其他
    • 产品
      • 静脉营养
      • 肠外营养
  • 市场分析、洞察与预测 - 依年龄组别划分
    • 成人
    • 儿童
  • 市场分析、洞察与预测 - 依给药途径划分
    • 口服
    • 鼻内给药
    • 肠外给药
    • 其他
  • 市场分析、洞察与预测 - 依剂量划分剂型
    • 粉剂
    • 液体
  • 市场分析、洞察与预测 - 依治疗领域划分
    • 肿瘤科
    • 神经系统疾病
    • 胃肠病科
    • 糖尿病
    • 肾病
    • 心血管疾病
    • 其他
  • 市场分析、洞察与预测 - 依最终用户划分
    • 医院及门诊手术中心
    • 专科诊所
    • 家庭医疗保健机构
    • 其他
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美医疗营养市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲医疗营养市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章：亚太地区医疗营养市场分析、洞察与预测（2019-2032）

  • 依国家/地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲医疗营养市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲医疗营养市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 海湾合作委员会
    • 南非
    • 中东和非洲其他地区

第十一章：竞争格局分析

  • 全球市占率分析（2024）
  • 公司简介
    • 雅培
    • 贝朗集团
    • 雀巢
    • 纽迪希亚（达能）
    • 百特
    • 费森尤斯卡比
    • 利洁时集团
    • Addus HomeCare, Inc.
    • 美德瑞集团
    • 味之素株式会社
Product Code: FBI112915

Growth Factors of medical nutrition Market

The global medical nutrition market continues to expand steadily as chronic diseases rise, awareness of clinical nutrition grows, and healthcare systems worldwide increasingly recognize the importance of nutrition therapy in both acute and long-term care. According to the report, the market size reached USD 51.26 billion in 2024, driven by an aging global population and increasing demand for medical nutrition therapy (MNT). The market is projected to grow further to USD 52.94 billion in 2025 and eventually reach USD 85.05 billion by 2032, reflecting a 7.0% CAGR during the forecast period. North America dominated the global market in 2024, accounting for 34.96% of total revenue due to its strong healthcare infrastructure, high prevalence of chronic diseases, and growing partnerships to advance clinical nutrition solutions.

Key Market Insights

Medical Nutrition Therapy (MNT) involves tailored nutrition interventions used to manage conditions such as diabetes, gastrointestinal disorders, cardiovascular diseases, chronic respiratory illness, and kidney disease. This treatment utilizes nutrition education and behavioral counseling delivered by clinical dietitians as part of multidisciplinary medical care. In recent years, demand has surged due to growing global awareness about the importance of nutrition in preventing and managing chronic conditions.

The market is semi-consolidated with major players such as Abbott, Nestle, Nutricia (Danone), B. Braun SE, Fresenius Kabi AG, and Reckitt Benckiser Group PLC. These companies continue to expand portfolios and secure regulatory approvals to introduce disease-specific and patient-focused nutritional products. For example, in April 2023, Nutricia launched a memory supplement in the U.S. to support synapse strengthening.

Market Dynamics

Drivers: Rising Burden of Chronic Diseases

The increasing prevalence of chronic illnesses significantly boosts market demand. Conditions such as cancer, Parkinson's disease, and neurological disorders often impair normal nutrient intake. According to the American Parkinson Disease Association, 1.3 million people in North America will be living with Parkinson's disease by 2030. Similarly, aging populations contribute heavily to chronic conditions requiring clinical nutrition. In the U.S., 17.3% of the population was aged 65+ in 2022, a number projected to reach 22.0% by 2040.

Growing awareness of home-based medical nutrition also fuels demand, as elderly patients increasingly prefer clinical nutrition services at home for convenience, improved mobility, and enhanced quality of life.

Restraints: Limited Reimbursement Policies

Coverage for medical foods and nutrition therapies varies widely across regions. While countries in Europe such as France, Germany, Spain, and the Netherlands offer substantial reimbursement, the U.S. provides limited coverage outside hospital settings. This restricts access for lower-income patients. Additionally, lack of financial incentives for research in clinical nutrition technologies can deter innovation.

Opportunities: AI-Powered Personalized Nutrition

Rising demand for disease-specific and personalized nutrition products creates significant opportunities for manufacturers. Companies such as Abbott are increasing R&D investments-USD 2,741.0 million in 2023-into AI-enhanced nutrition solutions for gastrointestinal disorders, immune health, and metabolic conditions. Advances in AI are enabling accurate nutrition delivery and real-time monitoring for critically ill patients.

Market Trends

A major trend in the market is the shift toward disease-specific formulations, such as those for oncology, renal disorders, and metabolic diseases. Companies are launching specialized formulas to improve treatment outcomes. For instance, Abbott introduced its Similac PM 60/40 metabolic formula to support infants with specific renal conditions.

Personalized nutrition is also gaining traction, particularly in Japan, where 53% of consumers express interest in tailored nutritional solutions. Additionally, global focus on preventive healthcare is rising, positioning clinical nutrition as an essential tool for disease prevention.

Regional Outlook

North America

North America led the global market with a value of USD 17.92 billion in 2024, supported by strong R&D, product launches, and collaborations. Companies frequently introduce new solutions at major U.S. medical conferences. Baxter's ExactaMix Pro launch in 2022 is an example of growing innovation in the region.

Europe

Europe held the second-largest share in 2024, driven by favorable reimbursement policies and strong research collaborations like the Fresenius Kabi-ESICM partnership supporting clinical nutrition education and critical care nutrition.

Asia Pacific

Asia Pacific is expected to grow moderately from 2025 to 2032, fueled by an expanding elderly population and rising awareness of disease-specific nutrition. Economic development and increased healthcare spending are supporting market expansion in China, India, and Japan.

Latin America and Middle East & Africa

These regions are witnessing steady growth due to improving healthcare access, rising chronic diseases, and increased awareness of nutrition therapy.

Conclusion

Driven by rising chronic diseases, aging populations, and increased focus on personalized care, the medical nutrition market will grow from USD 51.26 billion in 2024 to USD 85.05 billion by 2032. Continued innovation, AI-integrated nutrition solutions, and strategic collaborations will shape the future of clinical nutrition worldwide.

Growth rate CAGR of 7.0% from 2025-2032

Segmentation

By Type

  • Service
    • Nutrition Assessment
    • Meal Preparation & Delivery
    • Feeding Assistance
    • Others
  • Product
    • Enteral Nutrition
    • Parenteral Nutrition
  • Partial Parenteral Nutrition (PPN)
  • Total Parenteral Nutrition (TPN)

By Age Group

    • Adults
    • Pediatrics

By Route of Administration

  • Oral
  • Nasal
  • Parenteral
  • Others

By Form

  • Powder
  • Liquid

By Therapeutic Area

  • Oncology
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Diabetes
  • Kidney Disorders
  • Cardiovascular Disorders
  • Others

By End-user

  • Hospitals & ASCs
  • Specialty Clinics
  • Homecare Settings
  • Others

By Region

  • North America (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
    • U.S.
    • Canada
  • Europe ( By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Latin America (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Chronic Diseases, by Key Countries/Sub-regions, 2023/2024
  • 4.2. New Product Launches, by Key Players
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Service
      • 5.1.1.1. Nutrition Assessment
      • 5.1.1.2. Meal Preparation & Delivery
      • 5.1.1.3. Feeding Assistance
      • 5.1.1.4. Others
    • 5.1.2. Product
      • 5.1.2.1. Enteral Nutrition
      • 5.1.2.2. Parenteral Nutrition
        • 5.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 5.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 5.2. Market Analysis, Insights and Forecast - By Age Group
    • 5.2.1. Adults
    • 5.2.2. Pediatrics
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Nasal
    • 5.3.3. Parenteral
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Form
    • 5.4.1. Powder
    • 5.4.2. Liquid
  • 5.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 5.5.1. Oncology
    • 5.5.2. Neurological Disorders
    • 5.5.3. Gastrointestinal Disorders
    • 5.5.4. Diabetes
    • 5.5.5. Kidney Disorders
    • 5.5.6. Cardiovascular Disorders
    • 5.5.7. Others
  • 5.6. Market Analysis, Insights and Forecast - By End-user
    • 5.6.1. Hospitals & ASCs
    • 5.6.2. Specialty Clinics
    • 5.6.3. Homecare Settings
    • 5.6.4. Others
  • 5.7. Market Analysis, Insights and Forecast - By Region
    • 5.7.1. North America
    • 5.7.2. Europe
    • 5.7.3. Asia Pacific
    • 5.7.4. Latin America
    • 5.7.5. Middle East & Africa

6. North America Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Service
      • 6.1.1.1. Nutrition Assessment
      • 6.1.1.2. Meal Preparation & Delivery
      • 6.1.1.3. Feeding Assistance
      • 6.1.1.4. Others
    • 6.1.2. Product
      • 6.1.2.1. Enteral Nutrition
      • 6.1.2.2. Parenteral Nutrition
        • 6.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 6.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 6.2. Market Analysis, Insights and Forecast - By Age Group
    • 6.2.1. Adults
    • 6.2.2. Pediatrics
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Nasal
    • 6.3.3. Parenteral
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Form
    • 6.4.1. Powder
    • 6.4.2. Liquid
  • 6.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 6.5.1. Oncology
    • 6.5.2. Neurological Disorders
    • 6.5.3. Gastrointestinal Disorders
    • 6.5.4. Diabetes
    • 6.5.5. Kidney Disorders
    • 6.5.6. Cardiovascular Disorders
    • 6.5.7. Others
  • 6.6. Market Analysis, Insights and Forecast - By End-user
    • 6.6.1. Hospitals & ASCs
    • 6.6.2. Specialty Clinics
    • 6.6.3. Homecare Settings
    • 6.6.4. Others
  • 6.7. Market Analysis, Insights and Forecast - By Country
    • 6.7.1. U.S.
    • 6.7.2. Canada

7. Europe Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Service
      • 7.1.1.1. Nutrition Assessment
      • 7.1.1.2. Meal Preparation & Delivery
      • 7.1.1.3. Feeding Assistance
      • 7.1.1.4. Others
    • 7.1.2. Product
      • 7.1.2.1. Enteral Nutrition
      • 7.1.2.2. Parenteral Nutrition
        • 7.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 7.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 7.2. Market Analysis, Insights and Forecast - By Age Group
    • 7.2.1. Adults
    • 7.2.2. Pediatrics
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Oral
    • 7.3.2. Nasal
    • 7.3.3. Parenteral
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Form
    • 7.4.1. Powder
    • 7.4.2. Liquid
  • 7.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 7.5.1. Oncology
    • 7.5.2. Neurological Disorders
    • 7.5.3. Gastrointestinal Disorders
    • 7.5.4. Diabetes
    • 7.5.5. Kidney Disorders
    • 7.5.6. Cardiovascular Disorders
    • 7.5.7. Others
  • 7.6. Market Analysis, Insights and Forecast - By End-user
    • 7.6.1. Hospitals & ASCs
    • 7.6.2. Specialty Clinics
    • 7.6.3. Homecare Settings
    • 7.6.4. Others
  • 7.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.7.1. Germany
    • 7.7.2. U.K.
    • 7.7.3. France
    • 7.7.4. Italy
    • 7.7.5. Spain
    • 7.7.6. Scandinavia
    • 7.7.7. Rest of Europe

8. Asia Pacific Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Service
      • 8.1.1.1. Nutrition Assessment
      • 8.1.1.2. Meal Preparation & Delivery
      • 8.1.1.3. Feeding Assistance
      • 8.1.1.4. Others
    • 8.1.2. Product
      • 8.1.2.1. Enteral Nutrition
      • 8.1.2.2. Parenteral Nutrition
        • 8.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 8.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 8.2. Market Analysis, Insights and Forecast - By Age Group
    • 8.2.1. Adults
    • 8.2.2. Pediatrics
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Oral
    • 8.3.2. Nasal
    • 8.3.3. Parenteral
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Form
    • 8.4.1. Powder
    • 8.4.2. Liquid
  • 8.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 8.5.1. Oncology
    • 8.5.2. Neurological Disorders
    • 8.5.3. Gastrointestinal Disorders
    • 8.5.4. Diabetes
    • 8.5.5. Kidney Disorders
    • 8.5.6. Cardiovascular Disorders
    • 8.5.7. Others
  • 8.6. Market Analysis, Insights and Forecast - By End-user
    • 8.6.1. Hospitals & ASCs
    • 8.6.2. Specialty Clinics
    • 8.6.3. Homecare Settings
    • 8.6.4. Others
  • 8.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.7.1. China
    • 8.7.2. India
    • 8.7.3. Japan
    • 8.7.4. Australia
    • 8.7.5. Southeast Asia
    • 8.7.6. Rest of Asia Pacific

9. Latin America Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Service
      • 9.1.1.1. Nutrition Assessment
      • 9.1.1.2. Meal Preparation & Delivery
      • 9.1.1.3. Feeding Assistance
      • 9.1.1.4. Others
    • 9.1.2. Product
      • 9.1.2.1. Enteral Nutrition
      • 9.1.2.2. Parenteral Nutrition
        • 9.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 9.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 9.2. Market Analysis, Insights and Forecast - By Age Group
    • 9.2.1. Adults
    • 9.2.2. Pediatrics
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Oral
    • 9.3.2. Nasal
    • 9.3.3. Parenteral
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Form
    • 9.4.1. Powder
    • 9.4.2. Liquid
  • 9.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 9.5.1. Oncology
    • 9.5.2. Neurological Disorders
    • 9.5.3. Gastrointestinal Disorders
    • 9.5.4. Diabetes
    • 9.5.5. Kidney Disorders
    • 9.5.6. Cardiovascular Disorders
    • 9.5.7. Others
  • 9.6. Market Analysis, Insights and Forecast - By End-user
    • 9.6.1. Hospitals & ASCs
    • 9.6.2. Specialty Clinics
    • 9.6.3. Homecare Settings
    • 9.6.4. Others
  • 9.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.7.1. Brazil
    • 9.7.2. Mexico
    • 9.7.3. Rest of Latin America

10. Middle East & Africa Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Service
      • 10.1.1.1. Nutrition Assessment
      • 10.1.1.2. Meal Preparation & Delivery
      • 10.1.1.3. Feeding Assistance
      • 10.1.1.4. Others
    • 10.1.2. Product
      • 10.1.2.1. Enteral Nutrition
      • 10.1.2.2. Parenteral Nutrition
        • 10.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 10.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 10.2. Market Analysis, Insights and Forecast - By Age Group
    • 10.2.1. Adults
    • 10.2.2. Pediatrics
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Oral
    • 10.3.2. Nasal
    • 10.3.3. Parenteral
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Form
    • 10.4.1. Powder
    • 10.4.2. Liquid
  • 10.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 10.5.1. Oncology
    • 10.5.2. Neurological Disorders
    • 10.5.3. Gastrointestinal Disorders
    • 10.5.4. Diabetes
    • 10.5.5. Kidney Disorders
    • 10.5.6. Cardiovascular Disorders
    • 10.5.7. Others
  • 10.6. Market Analysis, Insights and Forecast - By End-user
    • 10.6.1. Hospitals & ASCs
    • 10.6.2. Specialty Clinics
    • 10.6.3. Homecare Settings
    • 10.6.4. Others
  • 10.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.7.1. GCC
    • 10.7.2. South Africa
    • 10.7.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Abbott
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. Financials (Based on Availability)
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. SWOT,Etc.
    • 11.2.2. B. Braun SE
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. Financials (Based on Availability)
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. SWOT,Etc.
    • 11.2.3. Nestle
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. Financials (Based on Availability)
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. SWOT,Etc.
    • 11.2.4. Nutricia (Danone)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. Financials (Based on Availability)
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. SWOT,Etc.
    • 11.2.5. Baxter
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. Financials (Based on Availability)
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. SWOT,Etc.
    • 11.2.6. Fresenius Kabi AG
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. Financials (Based on Availability)
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. SWOT,Etc.
    • 11.2.7. Reckitt Benckiser Group PLC
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. Financials (Based on Availability)
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. SWOT,Etc.
    • 11.2.8. Addus HomeCare, Inc.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. Financials (Based on Availability)
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. SWOT,Etc.
    • 11.2.9. Medtrition Inc.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. Financials (Based on Availability)
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. SWOT,Etc.
    • 11.2.10. Ajinomoto Co., Inc.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. Financials (Based on Availability)
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. SWOT,Etc.

List of Tables

  • Table 1: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 2: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 3: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 4: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 5: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 6: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 7: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 8: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 9: Global Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 10: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 11: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 12: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 13: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 14: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 15: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 16: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 17: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 18: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 19: North America Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 20: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Country, 2019-2032
  • Table 21: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 22: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 23: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 24: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 25: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 26: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 27: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 28: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 29: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 30: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 31: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 32: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 33: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 34: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 35: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 36: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 37: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 38: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 39: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 40: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 41: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 42: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 43: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 44: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 45: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 46: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 47: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 48: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 49: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 50: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 51: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 52: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 53: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 54: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 55: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 56: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 57: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 58: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 59: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 60: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Medical Nutrition Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Medical Nutrition Market Value Share (%), by Type, 2024 & 2032
  • Figure 3: Global Medical Nutrition Market Value Share (%), by Age Group, 2024 & 2032
  • Figure 4: Global Medical Nutrition Market Value Share (%), by Route of Administration, 2024 & 2032
  • Figure 5: Global Medical Nutrition Market Value Share (%), by Form, 2024 & 2032
  • Figure 6: Global Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024 & 2032
  • Figure 7: Global Medical Nutrition Market Value Share (%), by End-user, 2024 & 2032
  • Figure 8: Global Medical Nutrition Market Value (USD billion), by Region, 2024 & 2032
  • Figure 9: North America Medical Nutrition Market Value (USD billion), by Type, 2024 & 2032
  • Figure 10: North America Medical Nutrition Market Value Share (%), by Type, 2024
  • Figure 11: North America Medical Nutrition Market Value (USD billion), by Age Group, 2024 & 2032
  • Figure 12: North America Medical Nutrition Market Value Share (%), by Age Group, 2024
  • Figure 13: North America Medical Nutrition Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 14: North America Medical Nutrition Market Value Share (%), by Route of Administration, 2024
  • Figure 15: North America Medical Nutrition Market Value (USD billion), by Form, 2024 & 2032
  • Figure 16: North America Medical Nutrition Market Value Share (%), by Form, 2024
  • Figure 17: North America Medical Nutrition Market Value (USD billion), by Therapeutic Area, 2024 & 2032
  • Figure 18: North America Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024
  • Figure 19: North America Medical Nutrition Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 20: North America Medical Nutrition Market Value Share (%), by End-user, 2024
  • Figure 21: North America Medical Nutrition Market Value (USD billion), By Country, 2024 & 2032
  • Figure 22: North America Medical Nutrition Market Value Share (%), By Country, 2024
  • Figure 23: Europe Medical Nutrition Market Value (USD billion), by Type, 2024 & 2032
  • Figure 24: Europe Medical Nutrition Market Value Share (%), by Type, 2024
  • Figure 25: Europe Medical Nutrition Market Value (USD billion), by Age Group, 2024 & 2032
  • Figure 26: Europe Medical Nutrition Market Value Share (%), by Age Group, 2024
  • Figure 27: Europe Medical Nutrition Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 28: Europe Medical Nutrition Market Value Share (%), by Route of Administration, 2024
  • Figure 29: Europe Medical Nutrition Market Value (USD billion), by Form, 2024 & 2032
  • Figure 30: Europe Medical Nutrition Market Value Share (%), by Form, 2024
  • Figure 31: Europe Medical Nutrition Market Value (USD billion), by Therapeutic Area, 2024 & 2032
  • Figure 32: Europe Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024
  • Figure 33: Europe Medical Nutrition Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 34: Europe Medical Nutrition Market Value Share (%), by End-user, 2024
  • Figure 35: Europe Medical Nutrition Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 36: Europe Medical Nutrition Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 37: Asia Pacific Medical Nutrition Market Value (USD billion), by Type, 2024 & 2032
  • Figure 38: Asia Pacific Medical Nutrition Market Value Share (%), by Type, 2024
  • Figure 39: Asia Pacific Medical Nutrition Market Value (USD billion), by Age Group, 2024 & 2032
  • Figure 40: Asia Pacific Medical Nutrition Market Value Share (%), by Age Group, 2024
  • Figure 41: Asia Pacific Medical Nutrition Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 42: Asia Pacific Medical Nutrition Market Value Share (%), by Route of Administration, 2024
  • Figure 43: Asia Pacific Medical Nutrition Market Value (USD billion), by Form, 2024 & 2032
  • Figure 44: Asia Pacific Medical Nutrition Market Value Share (%), by Form, 2024
  • Figure 45: Asia Pacific Medical Nutrition Market Value (USD billion), by Therapeutic Area, 2024 & 2032
  • Figure 46: Asia Pacific Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024
  • Figure 47: Asia Pacific Medical Nutrition Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 48: Asia Pacific Medical Nutrition Market Value Share (%), by End-user, 2024
  • Figure 49: Asia Pacific Medical Nutrition Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 50: Asia Pacific Medical Nutrition Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 51: Latin America Medical Nutrition Market Value (USD billion), by Type, 2024 & 2032
  • Figure 52: Latin America Medical Nutrition Market Value Share (%), by Type, 2024
  • Figure 53: Latin America Medical Nutrition Market Value (USD billion), by Age Group, 2024 & 2032
  • Figure 54: Latin America Medical Nutrition Market Value Share (%), by Age Group, 2024
  • Figure 55: Latin America Medical Nutrition Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 56: Latin America Medical Nutrition Market Value Share (%), by Route of Administration, 2024
  • Figure 57: Latin America Medical Nutrition Market Value (USD billion), by Form, 2024 & 2032
  • Figure 58: Latin America Medical Nutrition Market Value Share (%), by Form, 2024
  • Figure 59: Latin America Medical Nutrition Market Value (USD billion), by Therapeutic Area, 2024 & 2032
  • Figure 60: Latin America Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024
  • Figure 61: Latin America Medical Nutrition Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 62: Latin America Medical Nutrition Market Value Share (%), by End-user, 2024
  • Figure 63: Latin America Medical Nutrition Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 64: Latin America Medical Nutrition Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 65: Middle East & Africa Medical Nutrition Market Value (USD billion), by Type, 2024 & 2032
  • Figure 66: Middle East & Africa Medical Nutrition Market Value Share (%), by Type, 2024
  • Figure 67: Middle East & Africa Medical Nutrition Market Value (USD billion), by Age Group, 2024 & 2032
  • Figure 68: Middle East & Africa Medical Nutrition Market Value Share (%), by Age Group, 2024
  • Figure 69: Middle East & Africa Medical Nutrition Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 70: Middle East & Africa Medical Nutrition Market Value Share (%), by Route of Administration, 2024
  • Figure 71: Middle East & Africa Medical Nutrition Market Value (USD billion), by Form, 2024 & 2032
  • Figure 72: Middle East & Africa Medical Nutrition Market Value Share (%), by Form, 2024
  • Figure 73: Middle East & Africa Medical Nutrition Market Value (USD billion), by Therapeutic Area, 2024 & 2032
  • Figure 74: Middle East & Africa Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024
  • Figure 75: Middle East & Africa Medical Nutrition Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 76: Middle East & Africa Medical Nutrition Market Value Share (%), by End-user, 2024
  • Figure 77: Middle East & Africa Medical Nutrition Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 78: Middle East & Africa Medical Nutrition Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 79: Global Medical Nutrition Market Share (%), By Company, 2024